CRISPR crops face regulatory and public acceptance obstacles

Screen Shot at PM

[Editor’s note: Armin Scheben is a PhD student and David Edwards is a professor at the School of Biological Sciences and Institute of Agriculture at the University of Western Australia.]

The global population is expected to rise from 7.3 billion to 9.7 billion by 2050. At the same time, climate change poses increasing risks to crop production through droughts and pests. Improved crops are thus urgently needed to meet growing demand for food and address changing climatic conditions. Genome-editing technologies such as the CRISPR … system show promise for helping to address these challenges, if the precision of genome editing is improved and the technology is approved and accepted by regulators, producers, and consumers.

[P]ublic acceptance of genome-edited crops is also required for their development to avoid the backlash that occurred previously with GMO crops. Smallholder farmers may also be unable to adopt new crop varieties because of lack of access to credit and market for seeds. Clarification on the regulation of genome-edited crops is urgently needed to support their development, and open public debate is required to give the public confidence in the safety and benefits of these crops. Coordinated efforts to help provide improved varieties to smallholder farmers and accelerate their adoption are also crucial to increase food security, particularly in developing countries.

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion, and analysis. Read full, original post: Genome editors take on crops (behind pay wall)

For more background on the Genetic Literacy Project, read GLP on Wikipedia

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot 2026-05-26 at 10.15
Viewpoint: Double standard—Why does the wellness industry get a free pass while Big Healthcare is treated as morally suspect?
ChatGPT-Image-Jun-4-2026-11_49_36-AM-2
‘You don’t understand Tolkien’: Skeptic Pope trolls tech giants about the exaggerated, risk-less benefits of AI
ChatGPT-Image-Jun-4-2026-01_27_58-PM
Viewpoint—N.A.D.+: Why Gwenyth Paltrow’s heralded anti-aging supplement doesn’t work
Screenshot-2026-06-04-at-12.05.08-PM
Cases of brain inflammation surge as U.S. measles pandemic approaches 2000
Screenshot-2026-06-03-at-1.24.46-PM
Challenging anti-GMO disinformation: Why genetically-tweaked crops offer bushels of benefits
Screenshot 2025-07-30 at 10.48
Can gene editing eliminate Down syndrome? Scientists have done it in lab-grown cells
ChatGPT Image May 26, 2026, 08_42_17 AM (1)
Viewpoint: Greenpeace and poison: How environmental advocacy groups rely on compliant (and often ignorant) journalists to spread disinformation and spark litigation
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
downsyndrome_compilation_MID_1
CRISPR breakthrough that can remove the chromosome responsible for Down syndrome raises ethical questions
tick-DNA
GLP podcast: Spread meat allergy with gene-edited ticks? Bioethicists pose vile ‘thought experiment’
ChatGPT Image May 26, 2026, 08_21_36 AM
Limiting gender affirming interventions: Trump administration targets Texas even though it already bans youth access

Sorry. No data so far.

glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.